Joshua A. Kazam - 15 Jun 2022 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
/s/ Veer Bhavnagri, Attorney-in-Fact
Issuer symbol
ALLO
Transactions as of
15 Jun 2022
Net transactions value
$0
Form type
4
Filing time
17 Jun 2022, 16:58:30 UTC
Previous filing
09 Mar 2022
Next filing
29 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Award $0 +44,178 +17% $0.000000 303,063 15 Jun 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.